CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Q-Med AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Q-Med AB
Seminariegatan 21
Phone: +46 (0)18 474 90 00p:+46 018 474 90 00 Uppsala, 752 28  Sweden Ticker: QMEDQMED
This company is no longer actively traded on any major stock exchange.
Business Summary
Q-Med AB is a Sweden-based medical device company that develops, produces, markets and sells medical implants. Its products are based on the Company's patented technology, Non-Animal Stabilized Hyaluronic Acid (NASHA). The Company’s offering is divided into two product areas. The Esthetics product area features natural and degradable Restylane products for filling-out wrinkles and folds, contouring lips using simple procedures, defining facial contours and improving the quality of the skin. It offers also Macrolane VRF, a series of shaping body products. The Hospital Healthcare product area comprises Solesta, for the treatment of fecal incontinence; Deflux, for the treatment of a malformation of the urinary bladder in children, and Durolane, for the treatment of osteoarthritis of the knee and hip joints. Q-Med AB operates through a number of subsidiaries in Europe, North America, Latin America, Asia and rest of the world. It has its production facility in Uppsala, Sweden.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201012/31/2009Yes----

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board BengtAgerup 66 9/1/2010 1/1/1987
Interim Chief Executive Officer CarinaBolin 50 3/9/2011
Vice President, Chief Financial Officer AlexanderKotsinas 48 1/1/2008 1/1/2008
9 additional Officers and Directors records available in full report.

Business Names
Business Name
Q-Med AB
QMED

General Information
Number of Employees: 636 (As of 12/31/2010)
Outstanding Shares: 99,382,000 (As of 12/31/2010)
Shareholders: 13,341
Stock Exchange: STO
Fax Number: +46 (0)18-474 90 01


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023